$0.96
(Market cap
$20,565 Mln
Recently Viewed
Clear AllMarket cap
$20,565 Mln
Revenue (TTM)
$4,342 Mln
P/E Ratio
24.3
P/B Ratio
7.4
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$850 Mln
ROE
0.3 %
ROCE
16.6 %
Industry P/E
--
EV/EBITDA
14.5
Debt to Equity
0.9
Book Value
$17.7
EPS
$5.5
Face value
--
Shares outstanding
151,906,915
CFO
$7,410.11 Mln
EBITDA
$427.43 Mln
Net Profit
$-315.44 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Illumina (ILMN)
| -3.6 | 2.1 | -15.9 | 65.8 | -17.1 | -20.7 | -1.0 |
|
BSE Sensex
| -9.5 | 5.5 | -6.0 | -4.3 | 8.7 | 9.9 | 11.5 |
|
S&P 100
| 1.4 | 10.2 | 2.5 | 37.7 | 22.9 | 13.3 | 14.2 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Illumina (ILMN)
| -1.8 | -1.3 | -31.1 | -46.9 | 2.8 | 11.5 | 10.6 |
|
S&P 100
| 18.7 | 29.0 | 30.8 | -22.1 | 27.6 | 19.3 | 29.5 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Illumina (ILMN)
|
126.4 | 20,565.1 | 4,342.0 | 850.0 | 27.3 | 33.4 | 24.3 | 7.4 |
| 91.9 | 168,225.1 | 45,134.0 | 6,276.0 | 15.4 | 24.6 | 26.7 | 3.2 | |
| 154.5 | 56,420.2 | 21,923.0 | 1,757.0 | 12.0 | 6.9 | 25.4 | 1.7 | |
| 63.6 | 94,253.2 | 20,074.0 | 2,886.0 | 14.7 | 12.5 | 32.7 | 4.0 | |
| 178.3 | 137,138.0 | 24,568.0 | 3,614.0 | 18.3 | 7.1 | 38.4 | 2.7 | |
| 83.6 | 45,372.1 | 6,067.6 | 1,073.5 | 20.4 | 10.6 | 43.2 | 4.3 | |
| 556.5 | 46,918.5 | 4,303.7 | 1,059.5 | 31.7 | 66.2 | 45 | 29.2 | |
| 477.1 | 166,649.2 | 10,064.7 | 2,856.0 | 29.3 | 16.7 | 59.5 | 9.1 | |
| 326.4 | 129,885.3 | 25,116.0 | 3,246.0 | 17.9 | 15.1 | 40.3 | 5.7 | |
| 471.3 | 191,756.6 | 44,556.0 | 6,737.0 | 19.5 | 13.1 | 29.1 | 3.7 |
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and... consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. The company has a collaboration with Labcorp Holdings Inc. for the development of oncology treatments through applications of sequencing solutions across the healthcare ecosystem. It also has a data partnership with Center for Data-Driven Discovery in Biomedicine to advance research in pediatric cancer and rare disease. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California. Read more
CEO & Director
Mr. Jacob Thaysen Ph.D.
CEO & Director
Mr. Jacob Thaysen Ph.D.
Headquarters
San Diego, CA
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Illumina Inc (ILMN) is $126.40 (NASDAQ) as of 24-Apr-2026 10:36 EDT. Illumina Inc (ILMN) has given a return of -17.05% in the last 3 years.
The P/E ratio of Illumina Inc (ILMN) is 24.32 times as on 17-Apr-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
23.76
|
7.42
|
|
2024
|
-17.48
|
9.01
|
|
2023
|
-19.07
|
3.85
|
|
2022
|
-7.25
|
4.84
|
|
2021
|
78.38
|
5.56
|
The 52-week high and low of Illumina Inc (ILMN) are Rs 155.47 and Rs 73.86 as of 24-Apr-2026.
Illumina Inc (ILMN) has a market capitalisation of $ 20,565 Mln as on 17-Apr-2026. As per SEBI classification, it is a Large Cap company.
Before investing in Illumina Inc (ILMN), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.